Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYOpthea Meets Primary Endpoint in Phase 2b Study of OPT-302 in Wet AMDPREV STORYTurning Point Therapeutics Reports Second Quarter 2019 Financial and Operational Results